Innate Immunity Laboratory, Centre for Inflammatory Diseases, Department of Medicine, Monash University, Level 5, Block E, 246 Clayton Rd., Clayton, VIC, 3168, Australia,
Hepatol Int. 2008 May;2(Supplement 1):12-8. doi: 10.1007/s12072-008-9067-0. Epub 2008 Feb 27.
Acute and chronic infection with hepatitis B virus (HBV) is associated with an increased risk of developing liver disease including cirrhosis, decompensated liver disease, and hepatocellular carcinoma. The clinical presentation and natural history of HBV infection is mediated through complex interactions between the virus and the host immune response. HBV is not directly cytopathic to heptocytes; however, the interaction between the virus and the host immune response plays a central role in the pathogenesis of necroinflammation and liver fibrosis. Emerging data from immunopathogenesis studies in animal models and in vitro studies of liver biopsies from patients with chronic hepatitis B demonstrate a potentially important interaction between hepatitis B e antigen, HBV, and components of the innate immune response including Toll-like receptors, Kupffer cells, natural killer T-cells, and dendritic cells. These findings suggest that the innate immune response has an important role in influencing the outcome of acute and chronic HBV infection. The current knowledge regarding the interaction between HBV and components of the innate immune response during acute and chronic HBV infection is reviewed.
乙型肝炎病毒(HBV)的急性和慢性感染与肝脏疾病(包括肝硬化、肝功能失代偿和肝细胞癌)的发生风险增加有关。HBV 感染的临床表现和自然史是通过病毒与宿主免疫反应之间的复杂相互作用介导的。HBV 对肝细胞没有直接细胞毒性;然而,病毒与宿主免疫反应之间的相互作用在坏死性炎症和肝纤维化的发病机制中起着核心作用。来自动物模型的免疫发病机制研究和慢性乙型肝炎患者肝活检的体外研究的新数据表明,乙型肝炎 e 抗原、HBV 与先天免疫反应的成分(包括 Toll 样受体、库普弗细胞、自然杀伤 T 细胞和树突状细胞)之间存在潜在的重要相互作用。这些发现表明,先天免疫反应在影响急性和慢性 HBV 感染的结局方面起着重要作用。本文综述了急性和慢性 HBV 感染期间 HBV 与先天免疫反应成分之间相互作用的最新知识。